Season 3 · Episode 35
S3 | E35 | AI-driven vocal biomarkers and the future of clinical diagnostics - Henry @ Canary Speech
ThinkData Podcast · Dataworks Group Limited
November 23, 202525m 34s
Audio is streamed directly from the publisher (episodes.captivate.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Today I’m joined by Henry O’Connell, CEO & Founder of Canary Speech, the company pioneering AI-powered vocal biomarkers to detect diseases like Alzheimer’s, Parkinson’s, and other neurological and behavioural conditions, all through a 20–30 second voice sample.
In this episode, we explore:
- How Canary Speech was founded and where the idea came from
- Why holding 14 patents in vocal biomarker technology is such a competitive advantage
- How Canary ensures clinical-grade safety, trust, and bias mitigation in AI healthcare tools
- The latest innovations in aggression detection, neurological disorders & behavioural health
- How global regulation (U.S. vs Europe vs Asia) shapes adoption speed in healthcare AI
If you’re interested in AI, healthcare, digital biomarkers, clinical innovation, or the future of diagnostics, this episode is a must-listen.